RFK Jr. vs. Oz sets up clash on weight loss drug coverage
Two of President-elect Trump’s top health nominees are on a collision course as the incoming administration faces a crucial decision on coverage for groundbreaking anti-obesity drugs. Mehmet Oz, Trump’s pick to run the Centers for Medicare and Medicaid Services,
Elon Musk Admits To Using Weight Loss Medication Criticized By RFK Jr, Says He Prefers Mounjaro Over Miracle Drug Ozempic
“While no drug is without side effects, health problems associated with obesity almost certainly exceed the risks of GLP-1 agonists,” Musk said as early as Oct. 2023. GLP-1 agonists are a class of medications that can help manage Type 2 diabetes and obesity.
Health Care Health Care The Big Story MAHA leaders heading for clash over GLP-1 drugs Two of President-elect Trump’s top ...
Kennedy Jr.’s stance on the medication. Musk, one of President-elect Donald Trump’s closest confidants, has expressed his support for more widespread use of Ozempic to curb America’s ...
Should RFK Jr. be confirmed as HHS secretary, he will wield power over policy details that could shape the trajectory of U.S.
Keith Poulsen’s jaw dropped when farmers showed him images on their cellphones at the World Dairy Expo in Wisconsin in ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
Statements by Robert F. Kennedy Jr. and Elon Musk tap into a dispute over whether lifestyle changes or drugs are a better way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback